DR. PAUL TORNETTA III M.D.
Prescription History 1073561973
Orthopaedic Surgery in Boston, MA

Active since May 04, 2006PECOS EnrolledAccepts Medicare Assignment
725 ALBANY ST, SHAPIRO 4, SUITE B, BOSTON, MA 02118(617) 638-5633(617) 414-5226 Get Directions

NPPES record last updated: May 23, 2014. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PAUL TORNETTA III M.D., an active Orthopaedic Surgery specialist practicing in Boston, MA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Meloxicam, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
12
Total Claims
13
30-Day Fills
Meloxicam
Most Prescribed · 12 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by DR. PAUL TORNETTA III M.D. in 2024, with prescription volumes, average cost per fill, and MA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other MA PrescribersVs. MA Avg
Meloxicam12$3.86▼ below MA avg▼ Less than typical

About Meloxicam: Meloxicam is used to treat arthritis. Show more ▾

It reduces pain, swelling, and stiffness of the joints. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

In 2024, this provider wrote 12 Medicare prescriptions for Meloxicam, about a third of the volume of the typical Massachusetts prescriber of this medication (40.4). Medicare paid an average of $3.86 per fill, versus $4.24 statewide.

How often this provider prescribes it

This provider
12
MA average
40.4

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3.86
MA average
$4.24

This provider's average cost per fill is below the MA average for this medication.

13
30-Day Fills
standardized to 30-day supplies
364
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average MA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MA average cost per fill.

About this data. The prescription history for DR. PAUL TORNETTA III M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Orthopaedic Surgery prescribing approach at this Boston, MA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.